Revisión
Uso off-label de bevacizumab intravítreo en retinopatía del prematuro severa
Off-label use of intravitreal bevacizumab for severe retinopathy of prematurity
L.E. Alba
, R.A. Zaldua, R.A. Masini
Autor para correspondencia
Servicio de Oftalmolopediatría, Instituto Oftalmológico Argentino, IOFA, Buenos Aires, Argentina
Leído
1085
Vecesse ha leído el artículo
277
Total PDF
808
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2023 6 | 5 | 2 | 7 |
| 2023 3 | 5 | 0 | 5 |
| 2020 12 | 1 | 2 | 3 |
| 2020 11 | 1 | 0 | 1 |
| 2020 7 | 1 | 2 | 3 |
| 2020 6 | 1 | 0 | 1 |
| 2020 4 | 1 | 0 | 1 |
| 2020 2 | 10 | 0 | 10 |
| 2019 9 | 1 | 0 | 1 |
| 2019 2 | 1 | 2 | 3 |
| 2019 1 | 1 | 0 | 1 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 7 | 4 | 11 |
| 2018 1 | 10 | 0 | 10 |
| 2017 12 | 10 | 5 | 15 |
| 2017 11 | 18 | 4 | 22 |
| 2017 10 | 20 | 6 | 26 |
| 2017 9 | 25 | 10 | 35 |
| 2017 8 | 27 | 6 | 33 |
| 2017 7 | 26 | 5 | 31 |
| 2017 6 | 25 | 20 | 45 |
| 2017 5 | 28 | 5 | 33 |
| 2017 4 | 35 | 10 | 45 |
| 2017 3 | 34 | 30 | 64 |
| 2017 2 | 17 | 6 | 23 |
| 2016 1 | 18 | 4 | 22 |
| 2016 12 | 35 | 11 | 46 |
| 2016 11 | 44 | 8 | 52 |
| 2016 10 | 42 | 15 | 57 |
| 2016 9 | 83 | 9 | 92 |
| 2016 8 | 54 | 12 | 66 |
| 2016 7 | 34 | 3 | 37 |
| 2016 6 | 44 | 24 | 68 |
| 2016 5 | 40 | 19 | 59 |
| 2016 4 | 34 | 17 | 51 |
| 2016 3 | 35 | 19 | 54 |
| 2016 2 | 28 | 12 | 40 |
| 2015 11 | 0 | 2 | 2 |
| 2015 10 | 1 | 0 | 1 |
| 2015 7 | 1 | 0 | 1 |
| 2015 6 | 1 | 0 | 1 |
| 2015 4 | 2 | 1 | 3 |
| 2015 3 | 1 | 2 | 3 |
Mostrar todo
